Hepatitis B vaccine and the risk of CNS inflammatory demyelination on childhood

Neurology

Volumn 73, Issue 17, 2009, Pages 1426-

  Lievre M ^a   Costagliola, D ^b   Evans, S ^a   Fourrier, A ^a   Imbs, J L ^a   Levy Bruhl, D ^a   Merle, L ^a   Micallef, J ^a   Oger, E ^a  

^a French Pharmacovigilance Commission ^*

^b Epidemiology Working Group   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT HEPATITIS B VACCINE;

CENTRAL NERVOUS SYSTEM; DEMYELINATION; HEPATITIS B; LETTER; MULTIPLE SCLEROSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR;

BIOMEDICAL RESEARCH; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; DEMYELINATING DISEASES; EPIDEMIOLOGIC RESEARCH DESIGN; HEPATITIS B VACCINES; HUMANS; MULTIPLE SCLEROSIS; ODDS RATIO; RISK FACTORS; TIME FACTORS;

EID: 70350521874     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181bd1f7e     Document Type: Letter

References (1)

1. Y Mikaeloff G Caridade S Suissa M Tardieu Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood Neurology 72 2009 873 880